Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AFM28 |
Trade Name | |
Synonyms | AFM-28|AFM 28 |
Drug Descriptions |
AFM28 is a bispecific innate cell engager that redirects CD16A-positive NK cells towards CD123-positive tumor cells, potentially leading to antibody-dependent cellular cytotoxicity and decreased tumor growth (Blood (2022) 140 (Supplement 1): 8815-8816). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AFM28 | AFM28 | 0 | 1 |